Search research articles
Contact Us
Filters
Showing results (201-210 of 210) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 210 results.
The Journal of Infectious Diseases
|
February 1, 1997
Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge
R E Taffs, Y V Chernokhvostova, E M Dragunsky, et al.
Carcinogenesis
|
November 1, 1996
Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice
S Yamamoto, K Mitsumori, Y Kodama, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1996
Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway
H Moriyama, K Yokono, K Amano, et al.
Oncology Reports
|
February 22, 2001
Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice
C Maruyama, M Tomisawa, S Wakana, et al.
Clinical and Experimental Medicine
|
July 12, 2008
Fulminant type 1 diabetes mellitus observed in insulin receptor substrate 2 deficient mice
T Arai, H Hashimoto, K Kawai, et al.
Genes & Development
|
May 27, 1999
Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53
H Nozawa, E Oda, K Nakao, et al.
Journal of Virology
|
March 1, 1997
Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain
Y Koyanagi, Y Tanaka, J Kira, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
July 25, 2009
Reconsideration of insulin signals induced by improved laboratory animal diets, Japanese and American diets, in IRS-2 deficient mice
H Hashimoto, T Arai, A Mori, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 1, 1982
[Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1]
M Niimoto, T Hattori, I Itoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 2, 1998
[Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/platelet-derived endothelial cell growth factor and histological prognostic factor, and influences of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase levels. 5'-DFUR Joint Research Group in the Osaka Area for Gastric Cancer]
Y Yamasaki, K Kuwata, K Hioki, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 210) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 210 results.
The Journal of Infectious Diseases
|
February 1, 1997
Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge
R E Taffs, Y V Chernokhvostova, E M Dragunsky, et al.
Carcinogenesis
|
November 1, 1996
Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice
S Yamamoto, K Mitsumori, Y Kodama, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1996
Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway
H Moriyama, K Yokono, K Amano, et al.
Oncology Reports
|
February 22, 2001
Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice
C Maruyama, M Tomisawa, S Wakana, et al.
Clinical and Experimental Medicine
|
July 12, 2008
Fulminant type 1 diabetes mellitus observed in insulin receptor substrate 2 deficient mice
T Arai, H Hashimoto, K Kawai, et al.
Genes & Development
|
May 27, 1999
Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53
H Nozawa, E Oda, K Nakao, et al.
Journal of Virology
|
March 1, 1997
Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain
Y Koyanagi, Y Tanaka, J Kira, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
July 25, 2009
Reconsideration of insulin signals induced by improved laboratory animal diets, Japanese and American diets, in IRS-2 deficient mice
H Hashimoto, T Arai, A Mori, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 1, 1982
[Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1]
M Niimoto, T Hattori, I Itoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 2, 1998
[Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/platelet-derived endothelial cell growth factor and histological prognostic factor, and influences of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase levels. 5'-DFUR Joint Research Group in the Osaka Area for Gastric Cancer]
Y Yamasaki, K Kuwata, K Hioki, et al.
Page
of 21